Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland
暂无分享,去创建一个
Jos Jonkers | Hatice Yücel | I. Huijbers | C. Pritchard | J. Jonkers | M. van de Ven | M. Nethe | M. Boelens | S. Kas | S. Annunziato | Eva Schut | S. Klarenbeek | Anne Paulien Drenth | Micha Nethe | Sjoerd Klarenbeek | Martine H van Miltenburg | Stefano Annunziato | Marieke van de Ven | Colin Pritchard | Eva Schut | Sjors M Kas | Jessica Del Bravo | Rahmen Bin Ali | Bas van Gerwen | Bjørn Siteur | Mirjam C Boelens | Ivo J Huijbers | Bjorn Siteur | Bas van Gerwen | Hatice Yücel | M. V. van Miltenburg | J. Del Bravo | Rahmen Bin Ali | Bjørn Siteur
[1] J. Azzopardi,et al. Invasive lobular carcinoma of the breast: incidence and variants , 1979, Histopathology.
[2] M. Borst,et al. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. , 1993, Surgery.
[3] M. J. van de Vijver,et al. © 1997 Cancer Research Campaign , 2022 .
[4] I. Ellis,et al. Clinical and Biological Significance of E-cadherin Protein Expression in Invasive Lobular Carcinoma of the Breast , 2010, The American journal of surgical pathology.
[5] W. Birchmeier,et al. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. , 1993, The American journal of pathology.
[6] L. Ailles,et al. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences , 2000, Nature Genetics.
[7] Neville E. Sanjana,et al. Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.
[8] M. Taketo,et al. Hepatocarcinogenesis in Mice with β-Catenin and Ha-Ras Gene Mutations , 2004, Cancer Research.
[9] Zhiping Weng,et al. Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses. , 2015, Human gene therapy.
[10] M. Neville,et al. Transduction of the Mammary Epithelium with Adenovirus Vectors In Vivo , 2003, Journal of Virology.
[11] R. Kemler,et al. E-cadherin is a survival factor for the lactating mouse mammary gland , 2002, Mechanisms of Development.
[12] R. Roylance,et al. Multiple ways of silencing E‐cadherin gene expression in lobular carcinoma of the breast , 2001, International journal of cancer.
[13] A. Børresen-Dale,et al. The landscape of cancer genes and mutational processes in breast cancer , 2012, Nature.
[14] Francisco J. Sánchez-Rivera,et al. Rapid modeling of cooperating genetic events in cancer through somatic genome editing , 2014, Nature.
[15] Robert Langer,et al. CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling , 2014, Cell.
[16] L. Hennighausen,et al. Cre-mediated gene deletion in the mammary gland. , 1997, Nucleic acids research.
[17] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[18] Zhe Li,et al. Lineage Tracing of Mammary Epithelial Cells Using Cell-Type-Specific Cre-Expressing Adenoviruses , 2014, Stem cell reports.
[19] Christopher M. Vockley,et al. Epigenome editing by a CRISPR/Cas9-based acetyltransferase activates genes from promoters and enhancers , 2015, Nature Biotechnology.
[20] S. Linn,et al. Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene , 2001, Oncogene.
[21] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[22] R. Cardiff,et al. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting‡ , 2000, Oncogene.
[23] Mathias J Friedrich,et al. CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice , 2015, Proceedings of the National Academy of Sciences.
[24] Dian Yang,et al. Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing , 2015, Genes & development.
[25] C. Moskaluk,et al. Sustained activation of the HER1-ERK1/2-RSK signaling pathway controls myoepithelial cell fate in human mammary tissue. , 2011, Genes & development.
[26] S. Fiering,et al. Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer , 2014, Journal of visualized experiments : JoVE.
[27] Andrew J Ewald,et al. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. , 2008, Developmental cell.
[28] Steven J. M. Jones,et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer , 2015, Cell.
[29] A. Berns,et al. PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. , 2002, Development.
[30] B. van Steensel,et al. Easy quantitative assessment of genome editing by sequence trace decomposition , 2014, Nucleic acids research.
[31] I. Huijbers,et al. Using the GEMM-ESC strategy to study gene function in mouse models , 2015, Nature Protocols.
[32] J. Jonkers,et al. A preclinical mouse model of invasive lobular breast cancer metastasis. , 2013, Cancer research.
[33] Hanns Lochmüller,et al. High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression. , 1998, Human gene therapy.
[34] Jan Grimm,et al. A spatially and temporally restricted mouse model of soft tissue sarcoma , 2007, Nature Medicine.
[35] Jos Jonkers,et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. , 2006, Cancer cell.
[36] I. Huijbers,et al. Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer , 2015, Proceedings of the National Academy of Sciences.
[37] D. Ingber,et al. Intraductal Injection for Localized Drug Delivery to the Mouse Mammary Gland , 2013, Journal of visualized experiments : JoVE.
[38] R. Epstein,et al. Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy , 2014, BMC Cancer.
[39] I. Huijbers,et al. Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells , 2014, EMBO molecular medicine.
[40] Hao Yin,et al. CRISPR-mediated direct mutation of cancer genes in the mouse liver , 2014, Nature.
[41] J. Wesseling,et al. Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice , 2011, Disease Models & Mechanisms.
[42] L. Luo,et al. A global double‐fluorescent Cre reporter mouse , 2007, Genesis.
[43] Volker Hovestadt,et al. Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling , 2015, Nature Communications.